Abstract

Clozapine is licensed for treatment‐resistant schizophrenia. Clozapine dosage is normally adjusted according to each patient's clinical response and the side‐effect profile, but caution is advocated when using clozapine, due to its association with potentially life‐threatening side‐effects. One such adverse reaction is the risk of seizures. There is much debate as to how to prevent clozapine‐induced seizures: some authors recommend primary and some, secondary prophylaxis with antiseizure drugs. This article highlights an interesting case study and explores various factors that must be considered before a decision is made to prescribe anticonvulsant medication.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.